Difficult behaviors in long-term care patients with dementia

Journal of the American Medical Directors Association

Volumn 7, Issue 3, 2006, Pages 180-192

  Buhr, Gwendolen T ^a   White, Heidi K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Behavior; Dementia

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ASPARTATE AMINOTRANSFERASE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; DONEPEZIL; ESCITALOPRAM; FLUOXETINE; GALANTAMINE; HALOPERIDOL; MEMANTINE; MIRTAZAPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID; ZIPRASIDONE;

ANOREXIA; ANTICHOLINERGIC SYNDROME; ANXIETY; ATAXIA; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BODY WEIGHT DISORDER; CAREGIVER; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DEMENTIA; DIARRHEA; DISEASE COURSE; DISORIENTATION; DISTRESS SYNDROME; DIZZINESS; DRUG DOSE REGIMEN; EXTRAPYRAMIDAL SYNDROME; HEADACHE; HUMAN; INSOMNIA; LIVER DYSFUNCTION; LONG TERM CARE; MEDICAL ASSESSMENT; META ANALYSIS; METABOLIC DISORDER; MOTOR DYSFUNCTION; NAUSEA; ORTHOSTATIC HYPOTENSION; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SYMPTOM; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA; THROMBOCYTOPENIA; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 33244481274     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2005.12.003     Document Type: Article

References (94)

1. C.A. Cohen D.P. Gold K.I. Shulman J.T. Wortley G. McDonald M. Wargon Factors determining the decision to institutionalize dementing individuals: A prospective study Gerontologist 33 1993 714-720
2. R. Hebert M.F. Dubois C. Wolfson L. Chambers C. Cohen Factors associated with long-term institutionalization of older people with dementia: Data from the Canadian Study of Health and Aging J Gerontol A Biol Sci Med Sci 56 2001 M693-M699
3. K. Yaffe P. Fox R. Newcomer et. al. Patient and caregiver characteristics and nursing home placement in patients with dementia JAMA 287 2002 2090-2097
4. B.W. Rovner P.S. German J. Broadhead et. al. The prevalence and management of dementia and other psychiatric disorders in nursing homes Int Psychogeriatr 2 1990 13-24
5. B.W. Rovner S. Kafonek L. Filipp M.J. Lucas M.F. Folstein Prevalence of mental illness in a community nursing home Am J Psychiatry 143 1986 1446-1449
6. J. Cohen-Mansfield N. Billig Agitated behaviors in the elderly. I. A conceptual review J Am Geriatr Soc 34 1986 711-721
7. V. Patel T. Hope Aggressive behaviour in elderly people with dementia: A review Int J Geriatr Psychiatry 8 1993 457-472
8. L. Volicer A. Hurley E. Mahoney Behavioral symptoms of dementia L. Volicer A. Hurley Hospice Care for Patients With Advanced Progressive Dementia 1998 Springer New York, NY 68-87
9. M.B. Ryden K.S. Feldt Goal-directed care Caring for aggressive nursing home residents with dementia J Gerontol Nurs 18 1992 35-42
10. S.C. Burgener D. Barton Nursing care of cognitively impaired, institutionalized elderly J Gerontol Nurs 17 1991 37-43
11. T. Snow M. Bunn Accepting the Challenge [DVD] The Eastern North Carolina Chapter of the Alzheimer's Association 2003
12. L.D. Burgio A. Stevens K.L. Burgio D.L. Roth P. Paul J. Gerstle Teaching and maintaining behavior management skills in the nursing home Gerontologist 42 2002 487-496
13. P.D. Sloane J. Rader A.L. Barrick et. al. Bathing persons with dementia Gerontologist 35 1995 672-678
14. P.D. Sloane B. Hoeffer C.M. Mitchell et. al. Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: A randomized, controlled trial J Am Geriatr Soc 52 2004 1795-1804
15. B.W. Rovner C.D. Steele Y. Shmuely M.F. Folstein A randomized trial of dementia care in nursing homes J Am Geriatr Soc 44 1996 7-13
16. A.M. Chitsey B.K. Haight M.M. Jones Snoezelen A multisensory environmental intervention J Gerontol Nurs 28 2002 41-49
17. L. Volicer E. Mahoney E. Brown Nonpharmacological approaches to the management of the behavioral consequences of advanced dementia M. Kaplan S. Hoffman Behaviors in Dementia Best Practices for Successful Management 1998 Health Professions Press, Inc Baltimore, MD 155-176
18. J.C. van Weert A.M. van Dulmen P.M. Spreeuwenberg M.W. Ribbe J.M. Bensing Behavioral and mood effects of snoezelen integrated into 24-hour dementia care J Am Geriatr Soc 53 2005 24-33
19. C. Beck T. Modlin K. Heithoff V. Shue Exercise as an intervention for behavior problems Geriatr Nurs 13 1992 273-275
20. L. Camberg P. Woods W.L. Ooi et. al. Evaluation of simulated presence: A personalized approach to enhance well-being in persons with Alzheimer's disease J Am Geriatr Soc 47 1999 446-452
21. R. Remington Calming music and hand massage with agitated elderly Nurs Res 51 2002 317-323
22. J. Goddaer I.L. Abraham Effects of relaxing music on agitation during meals among nursing home residents with severe cognitive impairment Arch Psychiatr Nurs 8 1994 150-158
23. L.A. Gerdner Effects of individualized versus classical "relaxation" music on the frequency of agitation in elderly persons with Alzheimer's disease and related disorders Int Psychogeriatr 12 2000 49-65
24. H. Ragneskog L.A. Gerdner L. Hellstrom Integration of lucid individuals and agitated individuals with dementia in different care units J Clin Nurs 10 2001 730-736
25. M.A. Reimer S. Slaughter C. Donaldson G. Currie M. Eliasziw Special care facility compared with traditional environments for dementia care: A longitudinal study of quality of life J Am Geriatr Soc 52 2004 1085-1092
26. J. Cohen-Mansfield P. Werner The effects of an enhanced environment on nursing home residents who pace Gerontologist 38 1998 199-208
27. H.K. Kamel R.R. Hajjar Sexuality in the nursing home, part 2: Managing abnormal behavior-legal and ethical issues J Am Med Dir Assoc 4 2003 203-206
28. A.M. Levitsky N.J. Owens Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents J Am Geriatr Soc 47 1999 231-234
29. S.V. Wiseman J.W. McAuley G.R. Freidenberg D.L. Freidenberg Hypersexuality in patients with dementia: Possible response to cimetidine Neurology 54 2000 2024
30. K. Alagiakrishnan A. Sclater D. Robertson Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman J Am Geriatr Soc 51 2003 1326
31. C.A. Alessi E.J. Yoon J.F. Schnelle N.R. Al-Samarrai P.A. Cruise A randomized trial of a combined physical activity and environmental intervention in nursing home residents: Do sleep and agitation improve? J Am Geriatr Soc 47 1999 784-791
32. E.K. Mahoney L. Volicer A.C. Hurley Management of Challenging Behaviors in Dementia 2000 Health Professions Press Baltimore, MD
33. H.K. White E.S. McConnell C.W. Bales M. Kuchibhatla A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects J Am Med Dir Assoc 5 2004 89-97
34. R. Cowburn J. Hardy P. Roberts Neurotransmitter deficits in Alzheimer's disease D. Davies Alzheimer's disease: Towards an understanding of the aetiology and pathogenesis 1989 John Libbey & Company Ltd London, UK 9-32
35. K.L. Lanctot N. Herrmann P. Mazzotta Role of serotonin in the behavioral and psychological symptoms of dementia J Neuropsychiatry Clin Neurosci 13 2001 5-21
36. P.E. Lee S.S. Gill M. Freedman S.E. Bronskill M.P. Hillmer P.A. Rochon Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: Systematic review BMJ 329 2004 75-78
37. Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev2002:CD002852.
38. Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: Treatment of dementia and its behavioral disturbances. Postgraduate Medicine Special Report 2005;January:1-107.
39. B. Reisberg J. Borenstein S.P. Salob S.H. Ferris E. Franssen A. Georgotas Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment J Clin Psychiatry 48 Suppl 1987 9-15
40. I.R. Katz D.V. Jeste J.E. Mintzer C. Clyde J. Napolitano M. Brecher Risperidone Study Group Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial J Clin Psychiatry 60 1999 107-115
41. H. Brodaty D. Ames J. Snowdon et. al. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia J Clin Psychiatry 64 2003 134-143
42. L. Frank L. Kleinman G. Ciesla M.F. Rupnow H. Brodaty The effect of risperidone on nursing burden associated with caring for patients with dementia J Am Geriatr Soc 52 2004 1449-1455
43. P.P. De Deyn K. Rabheru A. Rasmussen et. al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia Neurology 53 1999 946-955
44. J.S. Street W.S. Clark K.S. Gannon et. al. The HGEU Study Group Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial Arch Gen Psychiatry 57 2000 968-976
45. J.L. Cummings M. Mega K. Gray S. Rosenberg-Thompson D.A. Carusi J. Gornbein The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia Neurology 44 1994 2308-2314
46. P.P. De Deyn M.M. Carrasco W. Deberdt et. al. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease Int J Geriatr Psychiatry 19 2004 115-126
47. C. Ballard M. Margallo-Lana E. Juszczak et. al. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial BMJ 330 2005 874-878
48. I.R. Katz Optimizing atypical antipsychotic treatment strategies in the elderly J Am Geriatr Soc 52 12 Suppl 2004 S272-S277
49. American Diabetes Association American Psychiatric Association American Association of Clinical Endocrinologists North American Association for the Study of Obesity Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 2004 596-601
50. Risperdal (risperidone) and cerebrovascular adverse events in placebo-controlled dementia trials. Dear Healthcare Professional Letter; October 11, 2002. Available at: www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/ risperdal1_e.pdf. Accessed January 5, 2005.
51. Dear Healthcare Professional Letter; April 16, 2003. Available at: www.fda.gov/medwatch/SAFETY/2003/risperdal.html. Accessed January 5, 2005.
52. N. Herrmann M. Mamdani K.L. Lanctot Atypical antipsychotics and risk of cerebrovascular accidents Am J Psychiatry 161 2004 1113-1115
53. EMEA public statement on the safety of olanzapine; March 9, 2004. Available at: www.emea.eu.int/pdfs/human/press/pus/085604en.pdf Accessed January 5, 2005.
54. Atypical antipsychotic drugs and stroke: Message from Professor Gordon Duff, Chairman, Committee on Safety of Medicines; March 9, 2004. Available at: http://www.mhra.gov.uk/home/groups/pl-p/documents/ drugsafetymessage/con019488.pdf. Accessed January 5, 2005.
55. FDA public health advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances; April 11, 2005. Available at: www.fda.gov/cder/drug/advisory/antipsychotics.htm. Accessed April 13, 2005.
56. CATIE: Clinical Antipsychotic Trials of Intervention Effectiveness. A research program studying treatment effectiveness and outcomes in schizophrenia and Alzheimer's disease. Available at: http://www.catie.unc.edu. Accessed January 12, 2005.
57. K.L. Lanctot N. Herrmann P. Mazzotta L.R. Khan N. Ingber GABAergic function in Alzheimer's disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia Can J Psychiatry 49 2004 439-453
58. J.M. Bjork F.G. Moeller G.L. Kramer et. al. Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder Psychiatry Res 101 2001 131-136
59. P.N. Tariot R. Erb C.A. Podgorski et. al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia Am J Psychiatry 155 1998 54-61
60. A.P. Porsteinsson P.N. Tariot R. Erb et. al. Placebo-controlled study of divalproex sodium for agitation in dementia Am J Geriatr Psychiatry 9 2001 58-66
61. P.N. Tariot L. Schneider J. Mintzer et. al. Safety and tolerability of divalproex sodium for the treatment of signs and symptoms of mania in elderly patients with dementia: Results of a double-blind, placebo-controlled trial Curr Ther Res Clin Exp 62 2001 51-67
62. R.C. Sival P.M. Haffmans P.A. Jansen S.A. Duursma P. Eikelenboom Sodium valproate in the treatment of aggressive behavior in patients with dementia - a randomized placebo controlled clinical trial Int J Geriatr Psychiatry 17 2002 579-585
63. J.L. Cummings C. Back The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease Am J Geriatr Psychiatry 6 2 Suppl 1 1998 S64-S78
64. Birks JS, Harvey R. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev2003:CD001190.
65. H. Feldman S. Gauthier J. Hecker B. Vellas P. Subbiah E. Whalen A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease Neurology 57 2001 613-620
66. P.N. Tariot J.L. Cummings I.R. Katz et. al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting J Am Geriatr Soc 49 2001 1590-1599
67. C. Holmes D. Wilkinson C. Dean et. al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease Neurology 63 2004 214-219
68. C. Courtney D. Farrell R. Gray et. al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000) Randomised double-blind trial Lancet 363 9427 2004 2105-2115
69. K. Rockwood J. Mintzer L. Truyen T. Wessel D. Wilkinson Effects of a flexible galantamine dose in Alzheimer's disease: A randomised, controlled trial J Neurol Neurosurg Psychiatry 71 2001 589-595
70. P.N. Tariot P.R. Solomon J.C. Morris P. Kershaw S. Lilienfeld C. Ding The Galantamine USA-10 Study Group A 5-month, randomized, placebo-controlled trial of galantamine in AD Neurology 54 2000 2269-2276
71. T. Erkinjuntti A. Kurz S. Gauthier R. Bullock S. Lilienfeld C.V. Damaraju Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease A randomised trial Lancet 359 9314 2002 1283-1290
72. M.R. Hynd H.L. Scott P.R. Dodd Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease Neurochem Int 45 2004 583-595
73. S. Bleich K. Romer J. Wiltfang J. Kornhuber Glutamate and the glutamate receptor system: A target for drug action Int J Geriatr Psychiatry 18 Suppl 1 2003 S33-S40
74. AreosaSA,SherriffF,McShaneR. Memantine for dementia. Cochrane Database Syst Rev2005:CD003154.
75. M.L. Levy J.L. Cummings R. Kahn-Rose Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease Gerontology 45 Suppl 1 1999 15-22
76. M.F. Weiner S.D. Edland H. Luszczynska Prevalence and incidence of major depression in Alzheimer's disease Am J Psychiatry 151 1994 1006-1009
77. B.W. Rovner J. Broadhead M. Spencer K. Carson M.F. Folstein Depression and Alzheimer's disease Am J Psychiatry 146 1989 350-353
78. A.S. Menon A.L. Gruber-Baldini J.R. Hebel et. al. Relationship between aggressive behaviors and depression among nursing home residents with dementia Int J Geriatr Psychiatry 16 2001 139-146
79. K.L. Lanctot N. Herrmann G. Eryavec R. van Reekum K. Reed C.A. Naranjo Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease Neuropsychopharmacology 27 2002 646-654
80. A.L. Nyth C.G. Gottfries The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study Br J Psychiatry 157 1990 894-901
81. B.G. Pollock B.H. Mulsant J. Rosen et. al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients Am J Psychiatry 159 2002 460-465
82. Y. Levkovitz Y. Bloch D. Kaplan A. Diskin I. Abramovitchi Fluvoxamine for psychosis in Alzheimer's disease J Nerv Ment Dis 189 2001 126-129
83. C.G. Lyketsos L. DelCampo M. Steinberg et. al. Treating depression in Alzheimer disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction: The DIADS Arch Gen Psychiatry 60 2003 737-746
84. G. Petracca A. Teson E. Chemerinski R. Leiguarda S.E. Starkstein A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease J Neuropsychiatry Clin Neurosci 8 1996 270-275
85. B.V. Reifler L. Teri M. Raskind et. al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression Am J Psychiatry 146 1989 45-49
86. L. Teri B.V. Reifler R.C. Veith et. al. Imipramine in the treatment of depressed Alzheimer's patients impact on cognition J Gerontol 46 1991 P372-P377
87. L. Teri R.G. Logsdon E. Peskind et. al. Treatment of agitation in AD: A randomized, placebo-controlled clinical trial Neurology 55 2000 1271-1278
88. C. Magai G. Kennedy C.I. Cohen D. Gomberg A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease Am J Geriatr Psychiatry 8 2000 66-74
89. S.I. Finkel J.E. Mintzer M. Dysken K.R. Krishnan T. Burt T. McRae A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil Int J Geriatr Psychiatry 19 2004 9-18
90. L. Teri D. Gallagher-Thompson Cognitive-behavioral interventions for treatment of depression in Alzheimer's patients Gerontologist 31 1991 413-416
91. R. Cheston K. Jones J. Gilliard Group psychotherapy and people with dementia Aging Ment Health 7 2003 452-461
92. W.P. Bouman G. Pinner Violent behavior associated with donepezil Am J Psychiatry 155 1998 1626-1627
93. P. Caffarra S. Majer M. Godani P. Paolello Rivastagmine-induced agitation following transient recollection of autobiographical memory Neurol Sci 22 2001 279-280
94. D.J. Smith S. Yukhnevich Adverse reactions to rivastigmine in three cases of dementia Aust N Z J Psychiatry 35 2001 694-695